Polycystic Ovary Syndrome Flashcards

1
Q

What is PCOS?

A
  • PCOS was first described in 1935 by American gynecologists Irving Freiler Stein and Michael Leventhal
  • Stein and Leventhal’s report titled “Amenorrhea associated with bilateral polycystic ovaries” described patients who showed features of polycystic ovaries, hyperandrogenism, and menstrual irregularities
  • Polycystic Ovarian Syndrome (PCOS) also referred to as Stein-Leventhal syndrome is one of the most common endocrine disorders affecting women of reproductive age.
  • It is a heterogeneous disease characterized by androgen excess (hyperandrogenism) and menstrual irregularities.
  • Many women presenting with PCOS have obesity (defined as a body mass index ≥ 30 mg/m2) and insulin resistance, which is a reduced biological response to insulin.

-It is now recognized as a major risk factor for the development of type 2 diabetes mellitus.

•5 - 15% women affected depending on the diagnostic criteria used

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Diagnosis of PCOS

A
  • The diagnosis of PCOS begins with a thorough history and physical examination.
  • Clinicians should focus on the patient’s menstrual history, any fluctuations in the patient’s weight, and other findings (e.g., hair in a male patter distribution, excessive acne).
  • Patients should also be asked about factors related to common comorbidities of PCOS.
  • The Endocrine Society advises clinicians to diagnose PCOS using the 2003 Rotterdam.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Dagnosis of PCOS - Rotterdam Criteria

A
  • hypergonadism
  • menstrual irregularity
  • polycystic ovaries on ultrasound

2/3 needed!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Other Diagnostic Guidlines

A

•There are a number of other abnormalities associated with PCOS including overweight/obesity, hypertension and insulin resistance. However, these conditions/diseases are not included in the diagnostic guidelines.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

PCOS Pathophysiology

A
  • Genetic and environmental (lifestyle) factors
  • Strong interplay between endocrine and metabolic factors
  • Patients with PCOS typically have increased LSH relative to FSH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Biochemical/Laboratory Criteria

A
  • Elevated serum levels of luteinizing hormone, testosterone and DHEA-S (dehydroepiandrosterone sulfate)
  • PCOS patients will show either normal or low levels of folliclestimulating hormone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pelvic Ultrasound

A

•12 follicles of a diameter ranging between 2 and 9 mm develop on one or both ovaries and/or the ovarian volume in at least one ovary exceeds 10 ml (10cm3)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Cysts

A
  • A polycystic ovary shows many follicles of a diameter ranging between 2 and 9 mm. The follicles group mainly round the periphery of the ovary
  • “Cysts” are antral follicles (secondary follicle) which have arrested in development
  • Polycystic ovaries are present in 20-30% of women and are not essential for the diagnosis of PCOS. The “cysts” in polycystic ovaries are not true cysts, but rather antral follicles which have arrested in development.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Hirsutism/Acne

A
  • Excess androgens may cause excess hair growth in a male pattern distribution and acne.
  • Excess androgens may cause excess hair growth in a male pattern distribution
  • Hirsutism: 70% of PCOS patients
  • The Ferriman-Gallwey scale is used for hirsutism.
  • A score of 1 to 4 is given for nine areas of the body.
  • A total score less than 8 is considered normal, a score of 8 to 15 indicates mild hirsutism, and a score greater than 15 indicates moderate or severe hirsutism.
  • A score of 0 indicates absence of terminal hair.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Obesity

A
  • In adult women, a waist circumference greater than or equal to 88 cm (35 inches) defines abdominal obesity
  • Overweight is defined as a body mass index (BMI) of 25.0 to less than 30.0 kg/m2 and obesity is defined as a BMI of 30.0 kg/m2 or greater
  • Obesity is present in approximately 50% of patients with PCOS
  • The obesity in women with PCOS is due to both an increase in visceral fat and subcutaneous fat.
  • Obesity in women with PCOS is due to both an increase in visceral fat and subcutaneous fat
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Risk Factors for PCOS

A
  • Family history of PCOS
  • Premature adrenarche
  • Low birth weight
  • Fetal androgen exposure
  • Excess insulin
  • Low grade inflammation
  • Sedentary Lifestyle
  • Diet
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Insulin Resistance

A
  • 70% of patients with PCOS exhibit metabolic abnormalities, including insulin resistance and hyperinsulinemia
  • Insulin resistance occurs when tissues such as adipose tissue, liver and skeletal muscles do not respond to insulin. This results in a compensatory increase in the secretion of insulin by the pancreas, causing hyperinsulinemia.
  • Insulin resistance and compensatory hyperinsulinemia are also risk factors for other metabolic diseases, including type 2 diabetes and atherosclerosis (PCOS patients typically exhibit dyslipidemia).
  • Insulin resistance is a risk factor for many diseases, including PCOS, type 2 diabetes and metabolic syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
A
17
Q

How do hyperinsulinemia and hyperandrogenism interplay together and contribute to PCOS?

A
  • Progesterone is the primary regulator of gonadotropin-releasing hormone (GnRH) pulse frequency.
  • In PCOS patients, the GnRH pulse generator is resistant to the negative feedback effects of progesterone.
  • This resistance to progesterone negative feedback is mediated by androgen excess.
  • The high GnRH pulse frequencies favor production of LH and limit production of FSH, which increases androgen production.
  • The resulting high levels of LH promotes androgen production and interferes with normal follicular development.
18
Q

How do hyperinsulinemia and hyperandrogenism interplay together and contribute to PCOS?

A
  • Insulin resistance is a feature of PCOS and is due to genetics, environment and obesity Insulin resistant patients compensate by secreting excess insulin from the pancreas (hyperinsulinemia).
  • Hyperinsulinemia results in the suppression of the sex-hormone-binding globulin (SHBG) and insulin growth factor binding protein 1 (IGFBP1) from the liver.
  • Increased insulin and IGF1 levels stimulate the secretion of androgens from the ovaries [and the adrenal glands], which results in hyperandrogenis.
  • The androgens enter tissues to exert their actions.
19
Q
A
20
Q
A
21
Q

Once Diagnosis is confirmed…

A

•Proceed with screening for type 2 diabetes mellitus, dyslipidemia, hypertension and psychiatric disorders:

  • Perform fasting glucose, insulin and hemoglobin A1c (HbA1c)
  • Perform 2 hour oral glucose tolerance test
  • Perform fasting lipid panel
  • Measure blood pressure
  • Evaluate for depression
22
Q

Management of PCOS

A
  • The treatment options for the patient are individualized based on their desire for ovulation/pregnancy.
  • To summarize, the management of PCOS includes the following:
  • Treatment of infertility
  • Menstrual regulation in women who do not desire pregnancy
  • Treatment of associated symptoms of hyperandrogenism (hirsutism, acne)
  • Lifestyle modifications (including exercise combined with proper nutrition) for treatment and prevention of the metabolic disturbances (i.e. obesity and insulin resistance)
23
Q

Treatment Options for Wmen Who Wish to Achieve Pregnancy

A
  • Women who wish to achieve pregnancy/ovulation induction –> Clomiphene
  • Hirsutism/Acne —> Depilatory/ Electrolysis
  • Obesity —> Lifestyle Modifications
  • Insulin Resistance/Menstrual Irregularities —> Metformin (Glucophage)
24
Q

Clomiphene

A
  • Description: Ovulation induction agent, selective estrogen receptor modulator
  • Manifestations treated: Infertility
  • Main adverse effects: Multiple pregnancy or ovarian hyperstimulation, thromboembolism
25
Q

Treatment Options for Wmen Who Need Contraception

A
  • Women who need contraception —> combination oral contraceptive pills
  • Hirsutism/Acne —> Depilatory/Electrolysis/ Spironolactone
  • Obesity —> Lifestyle Changes
  • Insulin Resistance/Menstrual Irregularities —> Metformin (Glucophage)
26
Q

Spironolactone

A
  • Description: Antiandrogenic (androgen antagonists)
  • Manifestations treated: Hirsutism Acne
  • Main adverse effects: Hyperkalemia, nausea
27
Q

Metformin (Glucophage)

A
  • Description: Insulin sensitizing agent
  • Manifestations treated: Insulin resistance (first-line therapy) Menstrual irregularities (second-line therapy)
  • Main adverse effects: Gastrointestinal upset
28
Q
A